# Losartan and Inflammation in Cystic Fibrosis

> **NCT03206788** · PHASE2 · TERMINATED · sponsor: **University of Miami** · enrollment: 7 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Losartan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03206788
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-11
- **Primary completion:** 2019-10-24
- **Final completion:** 2019-12-30
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** due to slow enrollment and approval of the Trikafta for CF patients
- **Last updated:** 2020-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03206788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03206788, "Losartan and Inflammation in Cystic Fibrosis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03206788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*